Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
Tetsuro Yoshimaru(Tokushima University), Toyomasa Katagiri(The University of Tokyo)
Cited by 80
Related Papers
PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast Cancer
|Cancer Research|2006|180
Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family
|Breast Cancer Research|2007|167
Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions
|Scientific Reports|2014|74
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells
|PLoS ONE|2015|31
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells
|Nature Communications|2017|23